In evaluation of XBP1/CD138/CS1 peptides-specific CTL with anti-MM activity, we confirmed that anti-LAG3 treatment induced enhanced proliferation of both CM and EM memory CTL subsets and their functional anti-MM activities including cytotoxicity and Th1-type cytokine production. The gene discussed is LAG3; the disease is Miyoshi myopathy.